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Evidence is accumulating that commonly used pesticides are linked to decline
of pollinator populations; adverse effects of three neonicotinoids on bees have
led to bans on their use across the European Union. Developing insecticides
that pose negligible risks to beneficial organisms such as honeybees is desir-
able and timely. One strategy is to use recombinant fusion proteins
containing neuroactive peptides/proteins linked to a ‘carrier’ protein that con-
fers oral toxicity. Hv1a/GNA (Galanthus nivalis agglutinin), containing an
insect-specific spider venom calcium channel blocker (v-hexatoxin-Hv1a)
linked to snowdrop lectin (GNA) as a ‘carrier’, is an effective oral biopesticide
towards various insect pests. Effects of Hv1a/GNA towards a non-target
species, Apis mellifera, were assessed through a thorough early-tier risk assess-
ment. Following feeding, honeybees internalized Hv1a/GNA, which reached
the brain within 1 h after exposure. However, survival was only slightly
affected by ingestion (LD50. 100 mg bee
21) or injection of fusion protein.
Bees fed acute (100 mg bee21) or chronic (0.35 mg ml21) doses of Hv1a/
GNA and trained in an olfactory learning task had similar rates of learning
and memory to no-pesticide controls. Larvae were unaffected, being able to
degrade Hv1a/GNA. These tests suggest that Hv1a/GNA is unlikely to
cause detrimental effects on honeybees, indicating that atracotoxins targeting
calcium channels are potential alternatives to conventional pesticides.1. Introduction
Pest control is an essential component of food security and agricultural pro-
ductivity, as herbivorous pests, weeds and pathogens can cause significant losses
in staple food crops unless control measures are in place [1]. Since the 1940s,
crop protection from insect pests has been reliant on synthetic chemical insecticides
such as DDT and organophosphates [2]; these chemicals improved yields, but with
a cost of negative consequences for non-target organisms, including humans [3]. To
overcome this, industrial producers have designed pesticides such as synthetic pyr-
ethroids, neonicotinoids and growth regulators with greater specificity for targeted
pests that are now used worldwide [4]. Neonicotinoids are general agonists of
insect nicotinic acetylcholine receptors, but bind onlyweakly to homologous recep-
tors in higher animals [5]. Their efficacy and low mammalian toxicity have led to
their widescale adoption, and they currently make up 24% of theworld insecticide
market [6]. However, several reports of adverse effects of neonicotinoids on ben-
eficial pollinating insects [7,8] have recently resulted in a controversial ban of the
use of three neonicotinoid pesticides (clothianidin, thiamenthoxam and imidaclo-
prid) by the European Commission. Insect pollination is an important ecosystem
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contributing to 35% of global food production in approximately
70% of crops [9]. Sublethal exposure to nectar-relevant doses of
neonicotinoids impairs the function of Kenyon cells in the hon-
eybee’s mushroom bodies [10] and reduces olfactory learning
and memory [7,11] and homing ability [12]. In bumblebees,
field-relevant, sublethal doses of these pesticides reduce fora-
ging success and cause failure of bee colonies [13]. While
neonicotinoids and other chemical pesticides clearly have nega-
tive impacts on pollinating bee species [13,14], banning them
without more appropriate alternatives could have significant
consequences for food production or biodiversity, if less specific
pesticides are used to replace them.
Potential alternatives to neonicotinoids and other chemical
pesticides include the development and use of biopesticides:
biological agents or bioactive compounds that often have
high specificity for target pest species [15]. Examples of cur-
rently used biopesticides include entomopathogenic fungi
[16], and toxins derived from the entomopathogenic bacterium
Bacillus thuringiensis [17]. Biopesticide candidates such as the
venom of predatory arthropods that target the voltage-gated
calcium ion channels (CaV) are very potent and selective
[18]. Since CaV channels are not highly conserved in insects,
this makes them attractive alternatives and represents a novel
mode of action to conventional pesticides.
Fusionprotein technology, inwhich insecticidal peptides are
linked to a plant lectin ‘carrier’ protein, has been developed
to allow proteins such as spider venom toxins to act as
orally delivered biopesticides. For example, v-hexatoxin-Hv1a
(Hv1a; also referred to elsewhere as v-atracotoxin-Hv1a or
v-ACTX-Hv1a) from the Australian funnel web spider Hadro-
nyche versuta acts on CaV channels in the insect central
nervous system (CNS), causing paralysis [19]. This toxin is
lethal to many insect species when injected, but does not affect
mammals [20]. When delivered orally it is essentially non-toxic
to insects, as it is unable to reach its site of action in the CNS.
Fusion of this insecticidal molecule to the carrier protein snow-
drop lectin (Galanthus nivalis agglutinin, GNA), allows Hv1a to
traverse the insect gut epithelium and access its sites of action,
producing an orally active insecticidal protein [21]. The Hv1a/
GNA fusion protein has oral insecticidal activity against insects
from a range of orders, including Lepidoptera, Coleoptera,
Diptera and Hemiptera.
Fusion protein biopesticides have the potential to improve
pest management strategies, but they have not yet been
tested on important insect pollinators such as bee species. In
Europe, laboratory-risk assessments of pesticides on bees cur-
rently include determination of acute contact and oral toxicity
on adult honeybees, following the guidelines from the Euro-
pean and Mediterranean Plant Protection Organization 170
[22] andOrganisation for Economic Co-operation andDevelop-
ment (OECD) 213 and 214 [23,24]. Despite conforming to these
criteria for assessing pesticide toxicity to bees, pesticides can
also exert a range of effects on pollinator behaviour at sublethal
and field-realistic concentrations that are not detectable by cur-
rent guidelines [25,26]. For example, subtle aspects of bee
behaviour important for foraging and survival, such as learning
and memory, can be impaired after prolonged exposure to pes-
ticides [7,8]. It is therefore sensible to assume thatmore rigorous
testing of pesticide toxicity to pollinating insects should be
implemented alongside the development of new biopesticide
products, to identify risks prior to their implementation in the
field and to reduce environmental impact.Here, we report the testing of the insecticidal fusion
protein Hv1a/GNA for toxicity to honeybees including the
recommended acute toxicity tests from the OECD guidelines
and in a test of cognitive function under both acute and long-
term exposure. We also address the issues involved in testing
pesticides on pollinators, suggesting that additional toxicity
tests, such as a chronic toxicity assay, and an evaluation of
any potential effects which pesticides may have on honeybee
behaviour should be adopted to assess critical factors for
bee viability and their role as pollinators.2. Material and methods
(a) Honeybees
Honeybee colonies (Apis mellifera mellifera) were originally
obtained from the National Bee Unit, York, UK, and were then
maintained at Newcastle University. During the summer months
(April–October 2012), bees were kept outdoors and allowed to
fly and forage freely. During the winter months (November
2012–March 2013), bees were maintained indoors, but were still
allowed to fly freely via a plastic pipe connecting the hive entrance
to the outdoors.
(b) Pesticides and toxins
Recombinant GNA, and the fusion protein Hv1a/GNA were
produced in the yeast expression system Pichia pastoris as
previously described [21,27]. The pesticide thiamethoxam
(TMX) (Sigma Aldrich, 99% purity) and the CaV channel blocker
benidipine HCl (Tocris Bioscience) were dissolved directly in 1 M
sucrose solution for oral administration to adult forager bees.
Acetamiprid (Ace) (Scotts) was obtained as a liquid formulation
(0.5% Ace, 1–5% ethanol, less than 1% of aqueous dipropylene
glycol solution of approx. 20% 1,2-benzisothiazolin-3-one,
5–10% glycerol).
(c) Toxicity studies
(i) Acute toxicity tests of Hv1a/GNA
Acute toxicity was assessed by injection, and by oral and contact
bioassays, using adult forager honeybees. Bees were collected
from outside the hive in small plastic vials and then cold anaes-
thetized to allow manipulation or transference to containers.
After all acute toxin administration regimes (see below), bees
were kept in 650 ml plastic storage containers fitted with 2 ml
microcentrifuge tubes that had four holes drilled in for bee
access. Bees were kept at 258C in the dark and allowed to feed
ad libitum on 50% w/v sucrose solution. Mortality was recorded
at 4, 24 and 48 h after exposure to the test compound.
Acute oral and contact toxicity assays were performed accord-
ing to the OECD guidelines [23,24]. For contact toxicity assays,
bees were cold anaesthetized and individually treated by topical
application of phosphate-buffered saline—Tween (PBST; 137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4.2H2O, 3 mM KH2PO4, pH
7.4, containing 0.05% Tween-20; negative control), GNA in PBST
(20 mg bee21), Hv1a/GNA in PBST (20 mg bee21) or Ace as the
positive control (4, 8.09 or 16.18 mg bee21, in PBST), directly
applied to the thorax using a micropipette. After application,
insects were separated into storage boxes as described above.
Ten bees were used per treatment, and each treatment replicated
seven times.
For the acute oral toxicity assays, insects were starved for
2 h prior to testing, in order to encourage active feeding during
the assay. Bees were collected, cold anaesthetized and placed
inside the storage containers, in replicates of 10 individuals
per container. After starvation bees were fed via a feeder with
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sucrose solution containing GNA (control; 100 mg bee21), Hv1a/
GNA (100 mg bee21), or Ace (positive control; 7.26, 14.52 or
29 mg bee21). Insects were allowed to feed, without restraint,
on the treatments for up to 4 h, after which these feeders were
removed and replaced with sucrose solution (50% w/v) feeders
to allow feeding ad libitum. Six replicates of 10 bees were used
for the negative control, GNA and Hv1a/GNA treatments,
whereas four replicates of 10 bees were used for each
concentration of the positive control.
Effects of the recombinant proteins were also evaluated by an
injection bioassay. Adult honeybees (30 per treatment) were cold
anaesthetized and injected into the thorax with either (i) 5 ml of
phosphate-buffered saline (PBS; as described above); (ii) 5 ml of a
4 mg ml21 GNA solution in PBS buffer (20 mg of GNAbee21)
or (ii) 5 ml of a 4 mg ml21 Hv1a/GNA solution in PBS buffer
(20 mg of Hv1a/GNAbee21) using a Hamilton syringe (Model
25F, needle gauge 25). After injection, bees were divided into
groups of 10 inside the storage containers.20140619(ii) Chronic toxicity tests of Hv1a/GNA
Bees were collected, anaesthetized, then transferred to storage
containers with feeding tubes as described above. Bees were
allowed to feed ad libitum for 7 days on one of three treatment
solutions: (i) 1 M sucrose, (ii) 350 mg ml21 Hv1a/GNA in 1 M
sucrose, or (iii) 10 ng ml21 TMX in 1 M sucrose. Bees were main-
tained in an incubator at 348C for the duration of the treatment
period, and mortality was recorded daily. Sample size was 40
bees per treatment group.(iii) Testing of Hv1a/GNA for acute toxicity towards
honeybee larvae
Standard operating procedures established for the in vitro testing
of pesticides were used to test for acute toxicity of Hv1a/GNA
towards honeybee larvae [28]. A single oral dose of 100 mg larva21
of Hv1a/GNA was administered to 4 day-old larvae individually
maintained in microtitre plate wells. Plates were incubated under
controlled environmental conditions at 348C in the dark, 60%relative
humidity. A total of 30 larvaewere treated alongside a control treat-
ment, in which larvae were fed on a diet with no added protein.
Fifteen larvae were sacrificed at 24 and 92 h after exposure to the
fusion protein to obtain haemolymph,whole larval anddiet samples
for western blot analysis to assess the stability of the fusion protein.
Haemolymph (at least 5 ml per insect) was obtained by piercing
pre-chilled larvae with a fine needle and collecting into pre-chilled
phenylthiocarbamide-phenol oxidase inhibitor to prevent melaniza-
tion. The survival of the remaining 15 larvae was monitored for
4 days subsequent to the single acute Hv1a/GNA dose.(d) Behavioural studies
(i) Acute Hv1a/GNA exposure for learning and memory
experiments
Forager bees were collected from outside the hive in small plastic
vials, cold anaesthetized and restrained in harnesses [29]. The
bees were fed 20 ml of 1 M sucrose solution, then left overnight
to become sufficiently hungry and motivated to perform the
olfactory learning task. One hour prior to the learning task,
each bee was fed 5 ml of treatment solution. The treatment
groups were: (i) a control group fed 5 ml of 1 M sucrose;
(ii) 100 mg of Hv1a/GNA in 5 ml of 1 M sucrose; (iii) 100 mg of
GNA in 5 ml of 1 M sucrose; and (iv) 500 ng of benidipine HCl
in 5 ml of 1 M sucrose. The experiment was repeated with three
cohorts, and the total sample size of trained bees was greater
than or equal to 20 bees per treatment group.(ii) Long-term Hv1a/GNA exposure for learning and
memory experiments
Foraging worker bees were collected and cold anaesthetized.
Ten bees were transferred to each feeding box (16.5  11 
6.5 cm) fitted with 2 ml microcentrifuge tubes with evenly
spaced holes for feeding the solutions. Bees were allowed to
feed ad libitum for 7 days on one of three treatment solutions:
(i) 1 M sucrose, (ii) 350 mg ml21 Hv1a/GNA in 1 M sucrose, or
(iii) 10 ng ml21 TMX (i.e. 10 ppb or 34 nM) in 1 M sucrose.
Bees were maintained in an incubator at 348C for the duration
of the treatment period, and mortality was recorded daily.
After this, the bees were cold anaesthetized and restrained in har-
nesses, fed 20 ml of treatment solution and left overnight to
become sufficiently motivated to perform the olfactory learning
task. The survival analysis was repeated four times (n ¼ 40 per
treatment group). A subset of bees was selected from these
cohorts for the olfactory conditioning assay.
(iii) Learning and memory experiments
An olfactory conditioning protocol based on the proboscis exten-
sion reflex (PER) was performed [29]. The conditioned stimulus
(CS; 1-hexanol) and unconditioned stimulus (0.2 ml of 1 M sucrose
solution) were presented for six training trials, with a 10 min
inter-trial interval. PER response to the CS was recorded. Two
unreinforced recall tests (the CS and a novel odour) were adminis-
tered at 10 min after conditioning and again at 24 h. The order of
presentation of these two test stimuli was pseudorandomized
across subjects.
(e) Detection of Hv1a/GNA in honeybee tissues
by western blotting
To test internalization of recombinant proteins, tissue samples were
collected from bees following 24 h feeding on either GNA or Hv1a/
GNA, as described above, using a modified version of the method
described by Mayack & Naug [30]. For haemolymph from adults,
insects were killed at2208C and immediately wrapped with Paraf-
ilm. The distal end of one of the antennae was cut and insects were
placed individually in microcentrifuge tubes. Tubes were spun for
30 s at 5000g and haemolymph collected and kept at 2808C until
use. Haemolymph was collected from larvae previously exposed
to the recombinant proteins after either 24 h (5 days-old larvae) or
92 h (8 days-old larvae), as detailed above. For brain samples from
adults, insects were cold anaesthetized, restrained in harnesses
and fed with 20 ml of 1 M sucrose solution (negative control) or
100 mgHv1a/GNAin 20 ml of 1 M sucrose solution.After 24 h, hon-
eybees were freeze-killed and the brains removed. Six brains from
each treatment were pooled and macerated in sodium dodecyl sul-
fate (SDS) sample buffer (100 mM Tris–HCl, pH 6.8, 4% SDS, 9%
glycerol, 2% 2-mercaptoethanol, 0.001% bromophenol blue).
Proteins from individual samples were separated in 15% SDS-
polyacrylamide gel electrophoresis (SDS-PAGE), transferred to
nitrocellulose membranes and screened for the presence of GNA
or Hv1a/GNA by SDS-PAGE followed by western blotting using
anti-GNA antibodies [21].
( f ) Statistical analysis
Log-rank Kaplan–Meier (K–M) survival analyses with pairwise
comparisons over strata were carried out using SPSS v. 19.0.
The median lethal dose (LD50) with 95% confidence intervals
(CIs) for positive controls on acute oral and contact bioassays
were estimated by plotting log dose versus probit of corrected
mortalities [31–33]. PER response during the learning and
memory tests was scored as a binary response, and data were
analysed in SPSS using a binary logistic regression (lreg). Data
from the first training trial were excluded from the analysis to
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Figure 1. Survival analyses indicate Hv1a/GNA poses no substantial toxicity towards adult honeybees. (a) Acute contact toxicity assay of GNA and Hv1a/GNA with
honeybees (20 mg of test protein per bee; n ¼ 70 bees per treatment). Survival curve for the positive control acetamiprid (Ace) (8.09 mg bee21) is shown.
(b) Acute oral toxicity bioassays of GNA (n ¼ 60) and Hv1a/GNA (n ¼ 60) with honeybees (100 mg of test protein per bee). Survival curve for positive control
Ace (14.52 mg bee21, n ¼ 40) is shown. (c) Effects of GNA and Hv1a/GNA on survival of honeybees following injection (20 mg of test protein per bee; n ¼ 30
bees per treatment). (d ) Honeybee survival was unaffected by chronic consumption of 21.7 mg bee21 day21 dose of Hv1a/GNA, but a 0.727 ng bee21 day21 dose
of thiamethoxam (TMX) increased mortality (n ¼ 40 bees per treatment). Dose–response curves for both acute contact and acute oral bee toxicity assays for all Ace
concentrations are presented in the electronic supplementary material, figure S1a,b, respectively. (Online version in colour.)
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treatments, time points and odours were performed using
least-squares post hoc comparisons (lsc). PER data represent the
mean probability of responding with a Wald x2 95% CI.3. Results
(a) Testing the acute and chronic toxicity of Hv1a/GNA
to honeybees
In order to assess the potential toxicity of Hv1a/GNA to pol-
linators, bioassays were carried out to measure the survival of
honeybees after exposure to the fusion protein (figure 1). The
Hv1a/GNA treatment regimens included acute contact and
oral exposure, acute injection, and a chronic 7-days oral
exposure; the neonicotinoids Ace and TMX, were used to
compare mortality caused by a neonicotinoid to that of the
fusion protein.
In the acute contact toxicity assays, the positive control
Ace induced bee mortality when compared to the negative
control (PBST), GNA control or Hv1a/GNA treatments
(figure 1a; K–M, PBST versus Ace, x21 ¼ 57:1, p, 0.001;
Hv1a/GNA versus Ace, x21 ¼ 49:9, p, 0.001; GNA versus
Ace, x21 ¼ 49:9, p, 0.001), with an estimated LD50 of
6.78+ 0.58 mg bee21, thus within the limits reported in the
literature [34]. When compared to the negative control,
neither Hv1a/GNA nor GNA increased mortality aftercontact exposure (K–M, Hv1a/GNA, x21 ¼ 1:34, p ¼ 0.246;
GNA, x21 ¼ 1:34, p ¼ 0.246) when applied at 20 mg bee21. It is
unlikely that the fusion protein or the GNA are able to cross
the insect cuticle, and thus a lack of toxicity in this assay
is expected.
In the acute oral treatments with the compounds, bees fed
the neonicotinoid, Ace, were the least likely to survive of all
treatments (figure 1b; K–M, sucrose versus Ace, x21 ¼ 56:3,
p, 0.001). The estimated LD50 for this compound was
8.95+ 0.23 mg bee21, which is comparable to those reported
for formulated products [35]. Survival of honeybees fed on
Hv1a/GNA or GNA at the maximum recommended dose
for oral toxicity assays (100 mg bee21) was reduced by 22%
for the fusion protein (K–M, sucrose versus Hv1a/GNA,
x21 ¼ 7:76, p ¼ 0.005) and 34% for the GNA (K–M, sucrose
versus GNA, x21 ¼ 16:7, p, 0.001). Survival of the bees fed
either Hv1a/GNA or GNA was greater than those fed aceta-
miprid (K–M, Hv1a/GNA versus Ace, x21 ¼ 35:5, p, 0.001;
GNA versus Ace, x21 ¼ 31:5, p, 0.001). We can therefore
conclude that Hv1a/GNA and GNA are of relatively low tox-
icity to honeybees as the oral LD50. 100 mg/bee. An acute
toxicity assay was also performed on larval honeybees: no
mortality was observed for either control or Hv1a/GNA
treatments, with 100% survival recorded 4 days post-treatment.
In order to exclude the possibility that low toxicity of Hv1a/
GNAwas owing to inefficient transport of theHv1a/GNA from
the gut to the haemolymph, toxicity of Hv1a/GNA and GNA
by injection was assessed to represent a ‘worst case scenario’.
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Figure 2. Hv1a/GNA consumption does not affect honeybee learning and memory. (a) The rate of learning is reduced in the positive control (the calcium channel
blocker, benidipine HCl; Ben), whereas acute exposure to Hv1a/GNA (Hv1a), or GNA, does not significantly influence olfactory learning relative to the control (Con).
Ncontrol ¼ 20, NGNA ¼ 20, NBen ¼ 23, NHv1a/GNA ¼ 23. (b) Short term memory (STM) was impaired for the Ben group, but not for the other treatments (lsc
comparisons against the control: GNA, p ¼ 0.740, Ben, p ¼ 0.025, Hv1a/GNA, p ¼ 0.661). (c) The rate of learning was not significantly different for bees fed
Hv1a/GNA for 7 days. Ncontrol ¼ 26, NHv1a/GNA ¼ 20. (d ) STM (10 min) and long term memory (24 h) were not significantly different for bees fed Hv1a/GNA
prior to conditioning; con, control; Hv1a, Hv1a/GNA. Data represent mean response probabilities+ 95% CIs. (Online version in colour.)
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over 48 h was greatest for those injected with GNA (57% mor-
tality; figure 1c; K–M, PBS versus GNA, x21 ¼ 23:4, p, 0.001;
GNA versus Hv1a/GNA, x21 ¼ 11:1, p¼ 0.001). While bees
injected with Hv1a/GNA also had significantly greater mor-
tality than the PBS control (K–M, PBS versus Hv1a/GNA,
x21 ¼ 5:35, p ¼ 0.021), mortality levels were relatively low
(,17%). These low levels were similar to the acute oral treat-
ment, confirming that only a very high dose of this compound
could produce measurable mortality in honeybees. Most of
this mortality occurred between the 24 and 48 h time points.
Previously, the Hv1a/GNA fusion protein has been
shown to be an effective insecticide when used as a foliar
spray; the protein is stable over timescales more than two
weeks under these conditions and provides continuing pro-
tection without the need for re-spraying (E. C. Fitches 2013,
unpublished data). The toxicity of chronic consumption of
Hv1a/GNA at the effective concentration when delivered
as a spray, 350 ppm (0.35 mg ml21), by adult forager honey-
bees was also investigated, and compared directly to the
chronic toxic effects of the neonicotinoid, TMX, at the concen-
trations reported in the nectar and pollen of treated crops
[36,37]. Each bee consumed on average 63.8+0.003 ml of
the control solution, 62.1+0.002 ml of the Hv1a/GNA sol-
ution and 72.7+0.004 ml of the TMX solution per day.
Based on the average volume of solution consumed per
day, the estimated dose of the Hv1a/GNA solution for eachbee was 21.7 mg bee21 day21, and the estimated dose of the
thiamethoxam for each bee was 0.727 ng bee21 day21. After
7 days of treatment, TMX treatment significantly increased
mortality compared to the other groups (figure 1d; K–M,
sucrose versus TMX, x21 ¼ 37:3, p, 0.001). In contrast to
this, there was no difference in survival between the control
group and the Hv1a/GNA treatment group (K–M, sucrose
versus Hv1a/GNA, x21 ¼ 1:16, p ¼ 0.282), again confirming
low toxicity of Hv1a/GNA to honeybees.
(b) Testing the effects of Hv1a/GNA on honeybee
learning and memory
Experiments based on an olfactory conditioning protocol
were performed to assess whether Hv1a/GNA affected olfac-
tory learning and memory in the honeybee following both
acute and long-term oral exposure (figure 2). Studies to
investigate potential effects of acute exposure also included
a positive control for testing the effects of a CaV channel
blocker on this behavioural parameter (benidipine hydrochlo-
ride; Ben), since a CaV channel is the target of the Hv1a toxin.
As shown in figure 2a, there was an overall difference in the
rate of learning between the different acute treatment groups
(lreg, x23 ¼ 30:7, p, 0.001). Ben (positive control) impaired
the rate of olfactory learning by up to 50% over the course
of six conditioning trials (lsc, p ¼ 0.026). The rate of learning
was unaffected when bees were treated with an acute dose of
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(figure 2a). Treatment influenced the expression of short-
term memory (STM, figure 2b); bees fed Ben had lower
responses than the control, GNA- or the Hv1a/GNA-treated
bees (lreg, STM, x23 ¼ 7:82, p ¼ 0.050; lsc for the control versus
Ben, p ¼ 0.025). However, when tested for long-term memory
(LTM) 24 h later, there was no significant difference in the
rate of response to the conditioned odour between the treat-
ment groups (lreg, LTM, x23 ¼ 4:67, p ¼ 0.197). For both
tests, the rate of response was always greater towards the con-
ditioned odour than a novel odour (data not shown, lreg,
STM, x21 ¼ 17:7, p, 0.001; LTM, x21 ¼ 10:3, p ¼ 0.001).
The effects of chronic oral exposure to Hv1a/GNA on
olfactory learning ability and memory were also tested. The
results showed that Hv1a/GNA did not influence the rate or
asymptotic level of learning when compared to the control
(lreg, x21 ¼ 2:69, p ¼ 0.107; figure 2c). Similarly, bees fed
Hv1a/GNA did not exhibit impaired STM or LTM per-
formance (lreg, STM, x21 ¼ 3:30, p ¼ 0.069; LTM, x21 ¼ 1:41,
p ¼ 0.235; figure 2d ). These results demonstrate that the
fusion protein HV1a/GNA does not impair olfactory learning
or memory formation, even though a positive control for the
same target as the fusion protein (Ben) significantly reduced
the rate of learning and STM.
(c) Detection of Hv1a/GNA in honeybee tissues
by western blotting
To investigate potential internalization of HV1a/GNA in
both adult and larval honeybees, tissue samples were col-
lected from insects fed on diet containing either GNA or
Hv1a/GNA 24 h after exposure and subsequently transferred
to diet without treatment for varying times. In adult bees, the
Hv1a/GNA fusion protein was clearly visualized in haemo-
lymph samples 24 h after feeding (figure 3a), demonstrating
that the GNA carrier component was able to direct transport
of the toxin component across the gut epithelium, as has been
observed in other insects [21]. Fusion protein was also detect-
able in brain tissue, showing that the toxin had been able to
reach its site of action in the CNS, and that the lack of toxicity
of Hv1a/GNAwas not owing to failure to transport or access
its target. As in adult bees, the western blotting experiment
for bee larvae showed evidence for transport of the GNA
carrier across the gut epithelium, since GNA was present
both in haemolymph and whole insect after feeding and
chase (24 and 92 h). However, no evidence for toxin transport
was seen, as all the fusion protein was degraded and no
intact Hv1a/GNA could be detected (figure 3b). As expected,
the levels of degraded protein, representing the GNA part of
the fusion protein, were reduced by the longer chase period
of 92 h compared with 24 h. The absence of toxicity of
Hv1a/GNA to larval bees is thus primarily owing to protein
degradation in the gut preventing transport of the toxin to its
sites of action, although on the basis of results from adult
bees, it is likely that the toxin would not affect calcium
channels if transported to the haemolymph.4. Discussion
The fusion protein Hv1a/GNA complies with the current
European and American risk assessments for pesticide toxicity
to honeybees, as tests described in the OECD guidelines werefulfilled [23,24]. Following those assays, acute oral and contact
toxicity of Hv1a/GNA can be considered negligible (LD50.
100 mg bee21). Even when bees were injected with Hv1a/
GNA, only 17% of the bees died within 48 h. In comparison,
lepidopteran larvae injected with comparable amounts of
fusion protein typically show a 90–100% reduction in survival
[21]. We assume this level of mortality in bees can be
considered low, as, according to the United States Environ-
mental Protection Agency, compounds with contact toxicity
of LD50. 11 mg bee
21 are classified as ‘relatively non-toxic’
[38]. This suggests that the omega toxin does not reach or
bind to the target site of action in the CNS of bees as avidly
as it does in lepidopteran larvae, or that there are critical differ-
ences in the ion channel binding sites in bees and lepidopteran
larvae. Surprisingly, the survival of bees injected with GNA
was significantly reduced (ca 60%), when compared with the
control treatment, whereas the injection of equivalent, high
doses of GNA into lepidopteran larvae does not result in sub-
stantial mortality. In our experiments, GNAwas only used as a
control, in the event that the fusion protein had an influence on
survival, learning and memory. Previous results of feeding
bioassays have suggested that plant lectins have differing
effects on insects, although the basis of this effect remains
unclear. Hv1a/GNA did not have a measurable influence on
survival or cognition in adult worker honeybees after acute
or long-term oral exposure. The observed lack of Hv1a/GNA
toxicity contrasts with lethal effects of neonicotinoids used as
positive controls: Ace was acutely toxic at similar concen-
trations to those previously reported [34], and chronic TMX
ingestion at a field-relevant dose had significant lethal effects
at the concentrations found in nectar and pollen [36,37].
No adverse effects of Hv1a/GNA on honeybee learning
and memory were detected in the assays reported here, in
spite of the fact that the doses we gave the bees prior to the
assay were relatively high. In fact, the chronic exposure
experiment is likely to have provided a dose to the bees far
above what they would experience in the field; this is because
the biopesticide is applied as a spray and not as a systemic
pesticide and so would not be consumed in large amounts
by bees in nectar and pollen. Previous studies have found
that exposure to field-relevant doses of pesticides which
target the CNS, such as neonicotinoids and organopho-
sphates, impair the ability of honeybees to learn and
remember the association between an olfactory cue and a
sucrose reward [7,8]. The effect of Hv1a on insect calcium
channels [20] suggests that it could have significant effects
on learning and memory, especially if CaV channels are
affected [39]. CaV channels are known to play a role in olfac-
tory learning in mammals [40] and are present in the areas of
the honeybee brain, where olfactory associations are pro-
cessed [41,42]. This prediction of CaV involvement in
honeybee learning was confirmed, as the positive control
for CaV block, benidipine HCl [43], impaired olfactory learn-
ing and STM. What was surprising, however, was that
benidipine HCl (used as a positive control) did not influence
long-term olfactory memory. A previous study of the influ-
ence of calcium on olfactory learning and memory in bees
showed that blocking intracellular calcium release prior to
conditioning impaired LTM formation [39]. Instead of block-
ing CaV channels as we did, however, this study used a
chelator of calcium to prevent calcium binding to CaV chan-
nels. By contrast, Hv1a/GNA had no significant effect on
olfactory learning or memory, indicating that at the doses
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Figure 3. Immuno-assay by western blotting demonstrates internalization of Hv1a/GNA in adult honeybee tissues. Bands of GNA (12 kDa) and Hv1a/GNA (FP;
16 kDa) are indicated. (a) Diagram of adult honeybee showing the presence of GNA and fusion protein Hv1a/GNA (FP) in both the haemolymph and brain
after feeding solutions containing proteins. Insects were fed 100 mg GNA or Hv1a/GNA, and haemolymph or brain tissue was collected after 24 h for analysis.
(b) Diagram of larval honeybee showing that Hv1a/GNA (FP) is degraded after ingestion; larvae were dosed with 100 mg Hv1a/GNA per larva and haemolymph
was collected after 24 h for analysis.
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the honeybee brain.
This lackof observedadverse effects oneither the survival or
the learning ability of adult honeybees was not owing to thefusion protein failing to reach the target site in the CNS. When
orally administered to adult worker honeybees, Hv1a/GNA
was capable of crossing the epithelial gut wall, as Hva1/GNA
immunoreactivity was detected in the haemolymph and brain
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larvae were capable of cleaving the fusion protein within the
digestive tract, preventing Hv1a/GNA from reaching the site
of action. A decline in gut proteolytic activity is known to
occur as bees develop into foragers [44,45], reflecting the high
protein content of the diet consumed by larval bees, in contrast
to the low-protein nectar diet consumed by adults.
Itwould appear that despite reaching theCNSof adult bees,
Hv1a/GNA does not block the CaV channels of Apis mellifera.
Conversely, another peptide isolated from H. versuta venom,
v-ACTX-Hv2a, has been shown to block CaV channels in
honeybee brain neurons [46]. Although this protein has a simi-
lar disulfide connection pattern to Hv1a, it has only limited
sequence similarity, which could account for differences in
toxicity towards bees. Hv1a has insecticidal activity against
Lepidoptera such as Helicoverpa armigera [47] and has been
shown to block CaV currents in CNS neurons from Drosophila
melanogaster, and the cockroach Periplaneta americana [19,20].
However, compared with other insecticide targets in the CNS
such as acetylcholine receptors and NaV channels, CaV chan-
nels are less well conserved between different insect orders
[48], thus conferring a certain degree of specificity. Functional
expression of recombinant CaV channels from different insect
orders would be necessary to fully elucidate the basis of this
differential sensitivity to Hv1a.
The data we report here suggest that Hv1a/GNA is a
potentially specific biopesticide, as it shows no adverse effectson the honeybee,Apis mellifera, an economically important pol-
linator, while being toxic to agronomically important insect
pests. Another possible reason for this lack of toxicity towards
honeybee is owing to its degradation within the bee, prevent-
ing accumulation of the fusion protein even if exposure is
repeated. The experiments we have performed exceed current
European and American requirements for pesticide safety, and
include an olfactory learning assay, which found no adverse
effects of Hv1a/GNA on this behavioural parameter. These
results show that Hv1a/GNA can be considered safer for
honeybees than some currently used pesticides, such as
neonicotinoids, although additional safety tests should be
performed to confirm its safety against other beneficial hyme-
noptera, such as bumblebees and parasitoid wasps. This study
also highlights the need to extend current guidelines for the
safety testing of new pesticides to include behavioural studies,
particularly for pollinating insects.Acknowledgements. The authors thank Malcolm Thompson for beekeep-
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